EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors. (4th November 2015)
- Record Type:
- Journal Article
- Title:
- EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors. (4th November 2015)
- Main Title:
- EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors
- Authors:
- Ellwanger, Kristina
Reusch, Uwe
Fucek, Ivica
Weichel, Michael
Gantke, Thorsten
Knackmuss, Stefan
Molkenthin, Vera
Marschner, Jens-Peter
Treder, Martin - Abstract:
- Is Part Of:
- Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
- Journal:
- Journal for immunotherapy of cancer
- Issue:
- Volume 3(2015)Supplement 2
- Issue Display:
- Volume 3, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 3
- Issue:
- 2
- Issue Sort Value:
- 2015-0003-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-11-04
- Subjects:
- Phage Display -- Apparent Affinity -- Target Cancer -- Cytotoxic Property -- Affinity Maturation
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105 - Journal URLs:
- http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/2051-1426-3-S2-P219 ↗
- Languages:
- English
- ISSNs:
- 2051-1426
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19196.xml